Description  Claims  Drawing  Cited references 

US61253857   [0001] 
US20100047297A   [0017] 
US5145684A   [0018]  [0022] 
US5510118A   [0019]  [0020] 
US4826689A   [0021]  [0095] 
WO0192293A   [0023]  [0095] 
US5314506A   [0024]  [0095] 
EP275607A   [0025] 
WO03059319A   [0026] 
US6197349B   [0027] 
US2006020905W   [0028] 
US20080227829A   [0029] 
US20070154540A   [0030] 
US20070189680A   [0031] 
US20060067905A   [0032] 
US20050271692A   [0035] 
US2006021625A   [0036] 
US7329797B   [0039] 
US20060229262A   [0040] 
EP1731134A1   [0043] 
EP1600143A1   [0044] 
US4603046A   [0045] 
DE10260872A1   [0046] 
DE10129973A1   [0047] 
WO0103652A2   [0048] 
WO9632095A   [0095] 
WO0044468A   [0095] 
WO0038811A   [0095] 
WO9832095A   [0095] 
WO9959709A   [0095] 

Apigenin and cancer chemoprevention: Progress, potential, and promise   [0003] 
Apigenin and cancer chemoprevention: Progress, potential, and promise,   [0009] 
Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol   [0009] 
Cell cycle arrest at G2/M and growth inhibition by apigenin in human cell colon carcinoma cell lines   [0009] 
The chemopreventative flavonoid apigenin induces G2/M arrest in keratinocytes   [0010] 
Arthritis Research & Therapy   [0012] 
Evaluation of Apigenin and [G-3H], Apigenin and analytical method development   [0013] 
Natural products: Potential source of COX inhibitors   [0016] 
Nonionic Surfactants: Physical Chemistry,   [0141] 
Pharmaceutical skin penetration enhancement   [0150] 
Re: Tentative Final Monograph for OTC Sunscreen   [0199] 
Pharmaceutical Research   [0207] 
Int Arch Allergy Immunol.   [0225] 
Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1.   [0226] 
FDA and AAPS Report of the Workshop on Principles and Practices of in vitro   [0297]